³í¹®) Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
°¡Å縯´ë¼¿ï¼º¸ðº´¿ø ¼Òȱ⳻°ú ÀåÁ¤¿ø ±³¼ö(±³½ÅÀúÀÚ), ºÎõ¼º¸ðº´¿ø À̽¿ø ±³¼ö(°øµ¿ Á¦1ÀúÀÚ), ÀÎõ¼º¸ðº´¿ø ±ÇÁ¤Çö ±³¼ö(°øµ¿ Á¦1ÀúÀÚ)